In this book, Feldman and Frondorf explain how companies employ strategies that block generic medicines from the market and keep prices high.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Robin Feldman is an award-winning teacher and scholar who has published more than forty articles and books. Feldman has been cited by the White House, members of Congress, and numerous federal agencies, and she has testified before committees of the US House and Senate, as well as the California legislature. In 2016, Feldman was named as one of the Women Leaders in Law and Technology, the only academic to receive the honor.
Inhaltsangabe
Introduction: big scandals, higher prices 1. The winding road to generic entry 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay 3. 'Generation 2.0': complicating pay-for-delay 4. 'Generation 3.0': new tactics for active obstruction of generics 5. 'Generation 3.0' continued: obstruction of regulatory pathways 6. Empirical evidence of a citizen's pathway gone astray Conclusion: a call for systematic reform.
Introduction: big scandals, higher prices 1. The winding road to generic entry 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay 3. 'Generation 2.0': complicating pay-for-delay 4. 'Generation 3.0': new tactics for active obstruction of generics 5. 'Generation 3.0' continued: obstruction of regulatory pathways 6. Empirical evidence of a citizen's pathway gone astray Conclusion: a call for systematic reform.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826